Basit öğe kaydını göster

dc.contributor.authorTaner, Neda
dc.date.accessioned2023-08-14T08:27:25Z
dc.date.available2023-08-14T08:27:25Z
dc.date.issued2023en_US
dc.identifier.citationTaner, N. (2023). Role of clinical pharmacists in post-COVID management. Acta Pharmaceutica Sciencia, 61(3), XXV-XXVI.en_US
dc.identifier.issn1307-2080
dc.identifier.urihttps://hdl.handle.net/20.500.12511/11313
dc.description.abstractAs the world begins to emerge from the COVID-19 pandemic, there is a critical need for healthcare providers to focus on post-COVID management. Clinical pharmacists can play a vital role in this effort, as they possess unique skills and expertise in medication management, patient education, and collaborative care. One of the key challenges in post-COVID management is addressing the long-term effects of the disease, commonly known as long COVID. Clinical pharmacists can help by assessing and managing the pharmacological treatment of these chronic conditions, as well as monitoring for potential drug interactions and adverse effects. In addition, clinical pharmacists can provide education to patients and other healthcare providers about the proper use of medications and the importance of medication adherence. This is especially important in the post-COVID era, as many patients may have experienced disruptions in their healthcare during the pandemic and may need support to resume their medication regimens. Finally, clinical pharmacists can work collaboratively with other healthcare providers, such as physicians and nurses, to optimize medication therapy and ensure that patients receive the best possible care. This includes reviewing medication orders, monitoring drug therapy, and providing recommendations for dose adjustments or alternative treatments. In conclusion, clinical pharmacists are well-positioned to play a critical role in post-COVID management. By leveraging their unique skills and expertise, they can help to address the long-term effects of the disease, provide education to patients and healthcare providers, and work collaboratively to optimize medication therapy.en_US
dc.language.isoengen_US
dc.publisherIstanbul Medipol Universityen_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectClinical Pharmacisten_US
dc.subjectCOVID-19en_US
dc.titleRole of clinical pharmacists in post-COVID managementen_US
dc.typeeditorialen_US
dc.relation.ispartofActa Pharmaceutica Scienciaen_US
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Klinik Eczacılık Ana Bilim Dalıen_US
dc.authorid0000-0002-6141-8676en_US
dc.identifier.volume61en_US
dc.identifier.issue3en_US
dc.identifier.startpageXXVen_US
dc.identifier.endpageXXVIen_US
dc.relation.publicationcategoryDiğeren_US
dc.institutionauthorTaner, Neda
dc.identifier.scopus2-s2.0-85165961673en_US
dc.identifier.scopusqualityQ3en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster